A clinical comparison of intrapleural heparin versus urokinase in the management of tuberculous pleurisy Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
Safety and efficacy of reduced dose intrapleural alteplase and DNAase for pleural infection Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018
Intrapleural use of dornase alfa and tissue plasminogen activator are successful as treatment in pediatric empyema: a pilot study Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018
Intrapleural fibrinolytic treatment with streptokinase for empyema during pregnancy: 2 cases Source: Annual Congress 2010 - Infections and pleural problems Year: 2010
Comparison between the administration of unfractionated heparin (UFH) and low molecular weight heparin (LMWH) in the treatment of pulmonary embolism Source: Annual Congress 2007 - Venous thromboembolic disease Year: 2007
Intrapleural urokinase in the management of empyema in children Source: Eur Respir J 2004; 24: Suppl. 48, 620s Year: 2004
One hour alteplase infusion plus low molecular weight heparin versus heparin alone in pulmonary embolism Source: Annual Congress 2003 - Pulmonary hypertension Year: 2003
Intrapleural fibrinolytic treatment of empyemas Source: Eur Respir J 2005; 26: Suppl. 49, 491s Year: 2005
Effect of heparin on gelatinases during lung preservation in rabbits Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome Year: 2017
Intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNAse) for pleural infection in an Asian population: Similar outcomes between 5mg and 10mg regimen Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018
Ten years experience of use of intrapleural streptokinase (IPSK) for empyema Source: Eur Respir J 2001; 18: Suppl. 33, 319s Year: 2001
Intrapleural instillation of fibrinolytics in the treatment complicated pneumonia in children. Case study Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002
Combination therapy with intrapleural doxycycline and talc in reduced doses for pleurodesis Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012
Combination is better than a single agent to create pleurodesis in rabbits Source: Eur Respir J 2005; 26: Suppl. 49, 446s Year: 2005
Intrapleural injection of pentoxifylline, a TNFa blocker, inhibit the pleurodesis induced by talc and doxycycline Source: Eur Respir J 2004; 24: Suppl. 48, 558s Year: 2004
Randomized trial of low-molecular-weight heparin compared with unfractionated heparin for acute pulmonary embolism Source: Eur Respir J 2001; 18: Suppl. 33, 382s Year: 2001
Comparison of low-molecular-weight-heparin and unfractionated heparin for acute PTE Source: Eur Respir J 2005; 26: Suppl. 49, 699s Year: 2005
The biological effect of intrapleural tissue plasminogen (tPA) activator and DNase delivery in pleural infection patients. Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018
Intrapleural administration of lipoplatin in an animal model Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010
Successful heparin desensitization after anaphylactic shock due to low molecular weight heparin Source: Eur Respir J 2005; 26: Suppl. 49, 134s Year: 2005